Kolon Life Science Acquires Additional 300,000 Shares of Kolon Biotech
[Asia Economy Reporter Heo Kyung-jun] Kolon Life Science, a KOSDAQ-listed company, announced on the 25th that it will additionally acquire 300,000 shares of its biopharmaceutical manufacturing subsidiary Kolon Biotech for approximately 5.6 billion KRW.
After the stock acquisition, Kolon Life Science's stake in Kolon Biotech will reach 100%. The scheduled date for the stock acquisition is the 26th.
Hot Picks Today
!["When Stock Prices Drop, It's an Opportunity"...Stocks Recommended by Analysts Amid Market Plunge [Weekend Money]](https://cwcontent.asiae.co.kr/asiaresize/93/2026071517222447576_1784103744.png)
"When Stock Prices Drop, It's an Opportunity"...Stocks Recommended by Analysts Amid Market Plunge [Weekend Money]
- "It Doesn't Matter Whose Car: Seoul Launches 'Half-Price for Pregnant Women' Policy"
- "Tariffs Must Be Increased Over Canadian Wildfire Smoke"... Trump Ramps Up Pressure
- "Eunma Apartment Fire That Killed High School Girl: Unlicensed Contractor Suspected of Faulty Electrical Work"
- Heo Jiwoong Delivers Harsh Criticism to Labor Minister: "Are You Following a Cult?"
Kolon Life Science stated that the purpose of this stock acquisition is "to secure liquidity for the subsidiary."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
